Rubric :   Actual

Drug-induced lupus erythematosus: current data on the mechanisms development and associated drugs
Authors: Golovach I.Yu. Yehudina Ye.D. №76 (2) 2019 / Review: 8
Differentiated approach to the treatment of osteoarthritis with comorbidities
Authors: Shuba N.M. Voronova T.D. Krylova A.S. Khambir T.S.... №68 (2) 2017 / Review: 1
UVEITIS in Patients with Juvenile Idiopathic Arthritis
Author:Boyko Y.Y. №66 (4) 2016 / Review: 2
BLOOD calprotectin (mrp-8/mrp-14) as sensitive diagnostic biomarker of systemic-onset juvenile idiopathic arthritis
Author:Boyko Y.Y. №65 (3) 2016 / Review: 1228
Substantiation report concerning retention of diagnosis «Juvenile rheumatoid arthritis» status in adult patients with a disease onset in childhood and adolescence
Authors: Kovalenko V.M. Shuba N.M. Yaremenko O.B. Оmelchenko L.I.... №63 (1) 2016 / Review: 1
The problem of transferring a patient with juvenile rheumatoid arthritis from child to adult rheumatologist
Author:Dzhus M.B. №61 (3) 2015 / Review: 2
The influence of TNF-α inhibitors on radiological progression in ankylosing spondylitis
Authors: Kovalenko V.M. Garmish E.A. Levchenko V.G. Romanovskiy A.V. №59 (1) 2015 / Review: 3
Biotechnological medicinal products and biosimilars: what clinicians should know when prescribing biosimilars
Authors: Talaeva T.V. Doroshchyk L.V. Kudriavtseva I.G. №59 (1) 2015 / Review: 2
ACUTE RHEUMATIC FEVER PROBLEMS
Authors: Lysenko G. Khimion L.V. №54 (4) 2013 / Review: 5790
CARDIOVASCULAR RISK STRATIFICATION AND CARDIOVASCULAR DISEASE PREVENTION IN RHEUMATOLOGIC PATIENTS CARE
Author:Garmish O.O. №54 (4) 2013 / Review: 1
BiologiC Drugs: WHAT’S the difference?
Authors: Kovalenko V.M. Bortkevych O.P. Rekalov D.G. Medvedchuk G.Y. №52 (2) 2013 / Review: 2
ACHIEVEMENTS TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №50 (4) 2012 / Review: 1